Wordt geladen...
Risk Factors for Delayed Elimination of Methotrexate in Children, Adolescents and Young Adults With Osteosarcoma
Background/Aim: High-dose methotrexate (HD-MTX) is pivotal chemotherapy in the treatment of patients with osteosarcoma. Blood concentrations of MTX are associated with several side effects, but there are large individual differences in the elimination of MTX. The aim of this study was to explore ris...
Bewaard in:
| Gepubliceerd in: | In Vivo |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
International Institute of Anticancer Research
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7811654/ https://ncbi.nlm.nih.gov/pubmed/33144454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12185 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|